A New Pathway for Protein Haptenation by β-Lactams

Area of Science:

• Photochemistry
• Proteomics
• Computational Chemistry
• Drug Metabolism

Background:

• Beta-lactam drugs are known to bind covalently to proteins.
• The established mechanism involves nucleophilic attack by lysine residues.
• Photoallergy is a potential adverse effect of some drugs.

Purpose of the Study:

• To investigate the covalent binding of beta-lactams to proteins upon photochemical activation.
• To elucidate a novel protein haptenation pathway for beta-lactam drugs.
• To understand the molecular basis of drug-protein interactions and photoallergy.

Main Methods:

• Integrated photochemical, proteomic, and computational studies.
• Use of human serum albumin (HSA) as a model protein.
• Ezetimibe as a beta-lactam probe.
• Docking and molecular dynamics simulations.

Main Results:

• A novel photochemical ring splitting of the beta-lactam ring was observed.
• A reactive ketene intermediate was formed and trapped by lysine residues.
• Covalent modification of Lys414 and Lys525 in HSA was identified.
• Photobinding may be a key step in photoallergy development.

Conclusions:

• A new beta-lactam-protein haptenation pathway via photochemical activation has been discovered.
• This pathway involves ketene intermediates and leads to amide adducts with lysine residues.
• Computational studies provide insights into the selectivity and mechanism of covalent modification, potentially explaining photoallergy.